Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

ENDRA Life Sciences (NDRA) Revenue (2016 - 2018)

ENDRA Life Sciences (NDRA) has disclosed Revenue for 3 consecutive years, with $6174.0 as the latest value for Q1 2018.

  • Quarterly Revenue changed N/A to $6174.0 in Q1 2018 from the year-ago period, while the trailing twelve-month figure was $6174.0 through Dec 2018, down 98.24% year-over-year, with the annual reading at $71224.0 for FY2025, 34.35% down from the prior year.
  • Revenue for Q1 2018 was $6174.0 at ENDRA Life Sciences, down from $6850.0 in the prior quarter.
  • The five-year high for Revenue was $515582.0 in Q4 2016, with the low at -$234802.0 in Q2 2016.
  • Average Revenue over 3 years is $106429.3, with a median of $32311.0 recorded in 2017.
  • Peak annual rise in Revenue hit 124.6% in 2017, while the deepest fall reached 98.67% in 2017.
  • Over 3 years, Revenue stood at $515582.0 in 2016, then crashed by 98.67% to $6850.0 in 2017, then dropped by 9.87% to $6174.0 in 2018.
  • According to Business Quant data, Revenue over the past three periods came in at $6174.0, $6850.0, and $287000.0 for Q1 2018, Q4 2017, and Q3 2017 respectively.